Related Experiment Video
Updated: Aug 29, 2025

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
Primary cutaneous SMARCA4-deficient undifferentiated malignant neoplasm: first two cases with clinicopathologic and
Eleanor Russell-Goldman1, Laura MacConaill2, John Hanna2
1Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. erussell-goldman@bwh.harvard.edu.
Abstract:
SMARCA4-deficient undifferentiated malignant neoplasms (SD-UMN) comprise a group of aggressive tumors with epithelioid morphology that are characterized by loss of function of SMARCA4, a component of the SWI/SNF chromatin remodeling complex. SD-UMN was first recognized in the thoracic cavity but is now appreciated to occur at multiple anatomic sites. A notable exception has been skin. Here we report the first two cases of primary cutaneous SD-UMN and compare their features to a cohort of eight visceral cases arising in lung, gastrointestinal tract, and gallbladder. Evidence for a bona fide cutaneous origin included extensive clinical, radiologic, and serologic analyses that failed to identify a metastatic source as well as the molecular identification of a UV-associated mutational pattern. The cutaneous cases showed strikingly similar morphologic, immunohistochemical, and molecular features to the visceral cases, strongly suggesting that they belong to this family of tumors. In addition to biallelic inactivation of SMARCA4, both cutaneous tumors also showed biallelic inactivation of TP53 and CDKN2A, findings which also appear common in visceral cases. One patient died of disease at 18 months after diagnosis, consistent with the aggressive nature of this tumor. Our results expand the anatomic spectrum of SD-UMN, adding this entity to an already challenging differential diagnosis that includes melanoma, squamous cell carcinoma, Merkel cell carcinoma, epithelioid sarcoma, and others. Given the potentially aggressive nature of SD-UMN, the timely and accurate diagnosis of this entity may have implications for prognosis and therapy.
Insights
This study reports the first cases of primary cutaneous SMARCA4-deficient undifferentiated malignant neoplasms (SD-UMN), aggressive tumors previously unrecognized in the skin. These findings expand the known locations for SD-UMN, aiding diagnosis and treatment.
Area of Science:
- Oncology
- Genetics
- Pathology
Background:
- SMARCA4-deficient undifferentiated malignant neoplasms (SD-UMN) are aggressive tumors characterized by SMARCA4 gene mutations.
- These neoplasms were initially identified in the thoracic cavity but have since been found in various visceral locations.
Observation:
- This study presents the first two cases of primary cutaneous SD-UMN.
- Clinical, radiological, and molecular analyses supported a skin origin, with evidence of UV-associated mutations.
- The cutaneous tumors exhibited similar morphological, immunohistochemical, and molecular characteristics to visceral SD-UMN.
Findings:
- Both cutaneous SD-UMN cases demonstrated biallelic inactivation of SMARCA4, TP53, and CDKN2A.
- These genetic alterations are also frequently observed in visceral SD-UMN.
- The aggressive nature of the tumor was highlighted by one patient's rapid disease progression.
Implications:
- The findings expand the anatomical spectrum of SD-UMN, including the skin.
- Accurate diagnosis is crucial for differentiating SD-UMN from other skin cancers like melanoma and Merkel cell carcinoma.
- Timely diagnosis impacts patient prognosis and therapeutic strategies for this aggressive neoplasm.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Abnormal Proliferation

